- –World market, 2023
- –Projected, 2033
- –Growth a year (CAGR)
- 952Active clinical trials worldwide
Most clinical trials
Active trials by country (ClinicalTrials.gov)
See every trial on ClinicalTrials.gov (opens in a new tab)
US
China
France
Italy
Germany
Spain
UK
CanadaAnemia Drugs by country and region
Australia
Brazil
Ecuador
Egypt
Hong Kong
India
Japan
Kenya
Malaysia
Mexico
New Zealand
Philippines
Russia
Saudi Arabia
Singapore
South Africa
Thailand
UAE"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 21,089 papers since 2021
- Safety and efficacy of immune checkpoint inhibitors and hypomethylating agents in treatment-naïve AML and HR-MDS: a systematic review and HR-MDS meta-analysis. Cancer treatment and research communications, 2026
- daNIS-2: a phase III, randomized, double-blind study of the anti-TGF-β monoclonal antibody NIS793 or placebo in combination with nab-paclitaxel/gemcitabine as first-line treatment in patients with metastatic pancreatic ductal adenocarcinoma. ESMO open, 2026
- Intracranial EWSR1::CREM fusion sarcoma presenting as a paraneoplastic inflammatory syndrome: illustrative case. Journal of neurosurgery. Case lessons, 2026
- Comparison of quality of life between docetaxel and weekly paclitaxel in the neoadjuvant or adjuvant treatment of breast cancer. Oncology, 2026
- From Birth to Burden: A Comprehensive Analysis of Health and Nutrition Inequities among Tribal Populations in India. Journal of racial and ethnic health disparities, 2026
Patients: Anaemia in women 15–49
| Place | Value | Year |
|---|---|---|
| World | 15.6 | 2023 |
| Australia | 11.1 | 2023 |
| Brazil | 21.3 | 2023 |
| Canada | 14.0 | 2023 |
| China | 15.6 | 2023 |
| Ecuador | 20.2 | 2023 |
| Egypt | 32.7 | 2023 |
| France | 13.1 | 2023 |
| Germany | 14.0 | 2023 |
| India | 53.7 | 2023 |
| Italy | 16.4 | 2023 |
| Japan | 18.7 | 2023 |
| Kenya | 32.2 | 2023 |
| Malaysia | 31.3 | 2023 |
| Mexico | 13.2 | 2023 |
| New Zealand | 12.4 | 2023 |
| Philippines | 12.0 | 2023 |
| Russia | 24.1 | 2023 |
| Saudi Arabia | 17.6 | 2023 |
| Singapore | 16.6 | 2023 |
| South Africa | 31.2 | 2023 |
| Spain | 15.6 | 2023 |
| Thailand | 20.7 | 2023 |
| UAE | 28.2 | 2023 |
| UK | 13.6 | 2023 |
| US | 15.0 | 2023 |
Key companies in Anemia Drugs
Sanofi
AbbVie Inc. (Allergan Plc)
Pharmacosmos A/S.
Covis Pharma GmbH.
Pfizer Inc. (Global Blood Therapeutics, Inc.)
GlaxoSmithKline plc.
Quick answers
How many clinical trials are running in Anemia Drugs?
ClinicalTrials.gov lists 952 active trials worldwide (recruiting, about to start or running), most of them in the US, as of 10 Nov 2026.
How much research is published on Anemia Drugs?
PubMed lists about 21,089 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Patients: WHO Global Health Observatory. Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.